Press Release Archived
Page 24 of 76
-
Attorney General Speaks Out As Member Of Men Make A Difference, Men Against Domestic Violence
Attorney General George Jepsen added his voice Tuesday to those standing up against domestic violence during a news conference Tuesday by members of Men Make A Difference, Men Against Domestic Violence.
-
Attorney General Raises Questions About Groupon Discounts In Connecticut
-
Attorney General Raises Questions About Citigroup Inc. Data Breach
-
Jepsen Urges State Regulators To Reject CL&P’s Plan To Replace Electric Meters
-
Attorney General Seeks DPUC Investigation Of Excess SCG Profits
-
Attorney General Statement On IDSA Guidelines Review Panel Report
-
Attorney General George Jepsen and state Department of Consumer Protection Commissioner Michelle H. Seagull today announced that Connecticut has joined with 41 other states and the District of Columbia in a $33 million settlement with Johnson & Johnson and Johnson & Johnson Consumer, Inc. to resolve allegations that the companies engaged in unfair or deceptive trade practices in the marketing of certain over-the-counter medications.
-
AG Jepsen Joins Alliance Supporting Paris Climate Agreement
Attorney General George Jepsen has joined with 18 other state attorneys general in signing an open letter affirming support for climate action to meet the Paris Climate Agreement.
-
Homeowners Mortgage Assistance Event Resources
Attorney General Jepsen today posted resources to help homeowners prepare for the Tuesday, November 15 Homeowners Mortgage Assistance Event.
-
Settlement Reached with CVS Pharmacy LLC Prohibits Sale of Expired Products in Connecticut
-
Attorney General Statement On State Supreme Court Education Funding Decision
-
Attorney General Submits Testimony Calling On Congress To Institute Internet Do-Not-Track
-
AG Jepsen: Conn. Taking Part in Multistate Investigation on Opioid Epidemic
Attorney General George Jepsen today announced that Connecticut is working with a bipartisan coalition of attorneys general from across the country on an ongoing investigation to evaluate whether pharmaceutical manufacturers have engaged in unlawful practices in the marketing and sale of prescription opioids.
-
The Kirby Company Agrees to Change Sales Practices and Restrict In-Home Sales Demonstrations
